Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

HIZAL M., ŞENDUR M. A. N. , YAŞAR H. A. , Bir Yucel K., Arslan C., Ucar G., ...More

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.26, no.7, pp.1583-1589, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 7
  • Publication Date: 2020
  • Doi Number: 10.1177/1078155219900908
  • Title of Journal : JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Page Numbers: pp.1583-1589
  • Keywords: Interferon, neutrophil-lymphocyte ratio, prognosis, renal cell cancer, tyrosine kinase inhibitors, PRETREATMENT NEUTROPHIL, INFLAMMATION, CANCER, IMPACT, PROGRESSION, VALIDATION

Abstract

Background